
Apple Mediserve Private Limited
About Apple Mediserve Private Limited
Data last updated:
Apple Mediserve Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 August 2022.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24290MP2022PTC062379. Its GSTIN is 23AAXCA5262G1ZH (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Lokesh Verma and Sushil Kumar Mandan.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indore, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.54 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.93 Cr (net margin 34.9%) and EBITDA of ₹2.63 Cr (EBITDA margin 47.4%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Apple Mediserve Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressApple Pharmacy Ground Floor Shop Apple Hospital 15/1 Transport Nagar Bhawarkua Main Ro, Ad, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Apple Mediserve Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Apple Mediserve is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Apple Mediserve Private Limited, buy the company report.
Financials of Apple Mediserve Private Limited
FY 2025 filings availableApple Mediserve Private Limited reported revenue of ₹5.54 Cr (up 1703% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.63 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹1.93 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 47.4% | ||
| Net Profit Margin | 34.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Apple Mediserve Private Limited, buy the company report.
Board of directors of Apple Mediserve Private Limited
Apple Mediserve has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lokesh Verma Also directs: Arpan News and Media Private Limited, Garg Civicon Private Limited, Ideatown Private Limited and 1 more | Director | 24 Aug 2022 | 4 Years 2 Months | Current |
| Sushil Kumar Mandan Also directs: Garg Civicon Private Limited, Aspin Jewellers Private Limited, Taikun Enterprises Private Limited and 2 more | Director | 12 Jul 2024 | 2 Years 3 Months | Current |
Peer comparison
Apple Mediserve Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Perfect Herbal Care Private Limited | ₹5.55 Cr (FY 2022) | 1261.0% | Delhi, India | |||
| Alpha Engineering and Systems Private Limited | ₹5.55 Cr (FY 2024) | -21.0% | Delhi, India | |||
| Global Foods Solutions Private Limited | ₹5.55 Cr (FY 2024) | -48.0% | Mumbai, Maharashtra, India | |||
| Mallikarjun Agro Processing Private Limited | ₹5.55 Cr (FY 2024) | 1158.0% | Kolhapur, Maharashtra, India | |||
| Laska Petcare Services Private Limited | ₹5.55 Cr (FY 2025) | -15.0% | Bangalore, Karnataka, India | |||
| Apple Mediserve Private Limitedthis company | ₹5.54 Cr (FY 2025) | ₹1.93 Cr | 34.9% | 1703.0% | Indore, Madhya Pradesh, India | |
| Ergosphere Ergonomics Private Limited | ₹5.54 Cr (FY 2025) | 30.0% | Gurgaon, Haryana, India | |||
| Kavita Pearls Private Limited | ₹5.54 Cr (FY 2024) | 7.0% | Dibrugarh, Assam, India | |||
| Vip Sweets Private Limited | ₹5.54 Cr (FY 2024) | 65.0% | Kolkata, West Bengal, India | |||
| Good Brands for A Healthy Life Private Limited | ₹5.54 Cr (FY 2025) | -2.0% | Bhiwandi, Maharashtra, India | |||
| Raj Mandir Retails Private Limited | ₹5.54 Cr (FY 2025) | 10.0% | New Delhi, Delhi, India |
To see the full peer comparison of Apple Mediserve Private Limited, buy the company report.
Auditor
Apple Mediserve Private Limited is audited by Ayushi Katariya & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ayushi Katariya & Associates | FY 2023 | 030697C |
Shareholding
The shareholding of Apple Mediserve Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Apple Mediserve Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Apple Mediserve Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apple Mediserve Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Apple Mediserve Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
GST
Apple Mediserve has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAXCA5262G1ZH | Madhya Pradesh | Active | 24 Jan 2024 |
To see the full GST registrations and return filing status of Apple Mediserve Private Limited, buy the company report.
Recent activity
Apple Mediserve Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Shashank Pokharna ceased to be Director on 20 Jul 2024.
Frequently asked questions
Apple Mediserve is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 August 2022 (4+ years old) and is registered under CIN U24290MP2022PTC062379.
Apple Mediserve has 2 current directors:
- Lokesh Verma - Director
- Sushil Kumar Mandan - Director
The latest financial statements of Apple Mediserve on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Apple Mediserve is 23AAXCA5262G1ZH, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Apple Mediserve is U24290MP2022PTC062379. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apple Mediserve was incorporated on 24 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Apple Mediserve by revenue are Perfect Herbal Care Private Limited, Alpha Engineering and Systems Private Limited, Global Foods Solutions Private Limited, Mallikarjun Agro Processing Private Limited, Laska Petcare Services Private Limited and 5 more, all in the same principal business activity (retail trading).
Shashank Pokharna ceased to be Director on 20 Jul 2024. Sushil Kumar Mandan was appointed as Director on 12 Jul 2024. Lokesh Verma was appointed as Director on 24 Aug 2022. Apple Mediserve has 4 board changes on record in total.
The registered office of Apple Mediserve is at Apple Pharmacy Ground Floor Shop Apple Hospital 151 Transport Nagar Bhawarkua Main Ro, Ad, Indore, Madhya Pradesh, India – 452001.
Apple Mediserve operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Apple Mediserve is compliant as of 26 August 2026. The company is actively filing with the Registrar of Companies.

